https://phaidra.vetmeduni.ac.at/o:1747 Allergic patients during the COVID-19 pandemic-Clinical practical considerations: An European Academy of Allergy and Clinical Immunology survey Alvaro-Lozano, Montserrat Montserrat Alvaro-Lozano 0000-0002-5528-8043 Pediatric Allergology and Clinical Immunology Hospital Sant Joan de Déu Barcelona / Universitat de Barcelona Pfaar, Oliver Oliver Pfaar 0000-0003-4374-9639 Philipps-Universität Marburg Bonini, Mateo Mateo Bonini Università Cattolica del Sacro Cuore Rome / Imperial College London Untersmayr, Eva Eva Untersmayr Medical University of Vienna Sturm, Gunter Gunter Sturm 0000-0002-7245-121X Medical University of Graz / Allergy Outpatient Clinic Brough, Helen Helen Brough 0000-0001-7203-0813 King's College Klimek, Ludger Ludger Klimek 0000-0002-2455-0192 Center for Rhinology and Allergology Wiesbaden Heffler, Enrico Enrico Heffler 0000-0002-0492-5663 University Milan / Clinical and Research Hospital IRCCS Chaker, Adam Adam Chaker Technical University of Munich Quecchia, Cristina Cristina Quecchia ASST Spedali Civili Brescia Tomic Spiric, Vesna Vesna Tomic Spiric University of Belgrade Sahiner, Umit Umit Sahiner 0000-0003-0088-913X Hacettepe University Jensen-Jarolim, Erika Erika Jensen-Jarolim 0000-0003-4019-5765 Medical University of Vienna / University of Veterinary Medicine Vienna / University of Vienna Giovannini, Mattia Mattia Giovannini 0000-0001-9568-6882 Allergy Unit Department of Pediatrics Meyer Children's University Hospital Florence Sandoval-Ruballos, Mónica Mónica Sandoval-Ruballos 0000-0002-8747-4799 Pediatric Allergology and Clinical Immunology Hospital Sant Joan de Déu Barcelona Wiley text eng The COVID-19 pandemic has affected health care systems unexpectedly. However, data focusing on practical considerations experienced by health care professionals (HCPs) providing care to allergic patients is scarce.Under the framework of the European Academy of Allergy and Clinical Immunology (EAACI), a panel of experts in the field of immunotherapy developed a 42-question online survey, to evaluate real-life consequences of the COVID-19 pandemic in allergy practice.The respondents in the survey were 618. About 80% of HCPs indicated being significantly affected in their allergy practice. A face-to-face visit reduction was reported by 93% of HCPs and about a quarter completely interrupted diagnostic challenges. Patients with severe uncontrolled asthma (59%) and anaphylaxis (47%) were prioritized for in-person care. About 81% maintained an unaltered prescription of inhaled corticosteroids (ICS) in asthmatics. About 90% did not modify intranasal corticosteroids (INCS) in patients with allergic rhinitis. Nearly half of respondents kept biological prescriptions unmodified for asthma. About 50% of respondents kept their allergen immunotherapy (AIT) prescription patterns unchanged for respiratory allergies; 60% for insect venom allergies. Oral immunotherapy (OIT) for food allergies was initiated by 27%. About 20% kept carrying out up-dosing without modifications and 14% changed to more prolonged intervals. Telemedicine practice was increased.HCPs providing care to allergic patients were affected during the pandemic in diagnostic, management, and therapeutic approaches, including AIT for respiratory, insect-venom, and food allergies. Most HCPs maintained controller treatments for both asthma, and allergic rhinitis consistent with international recommendations, as well as biological agents in asthma. Remote tools are valuable in delivering allergy care. allergen-immuntherapie; allergie; biologika; COVID-19; umfrage http://creativecommons.org/licenses/by/4.0/ https://phaidra.vetmeduni.ac.at/api/object/o:1747/download 10.1002/clt2.12097 https://phaidra.vetmeduni.ac.at/o:605 application/pdf Clinical and Translational Allergy 12(1) (2022) Clinical and Translational Allergy 12 1 694.51 kB 2022